| Literature DB >> 34258355 |
Andrea L Buras1, Jing Yi Chern1, Hye Sook Chon1, Mian M Shahzad1, Robert M Wenham1, Mitchel S Hoffman1.
Abstract
OBJECTIVE: Vascular injury during major gynecologic cancer surgery is a rare but potentially fatal complication. The purpose of this study was to review our experience with major vascular injury during gynecologic cancer surgery.Entities:
Keywords: Arterial injury; Gynecologic Surgery; Intraoperative injury; Vascular injury; Vascular repair; Venous injury
Year: 2021 PMID: 34258355 PMCID: PMC8259293 DOI: 10.1016/j.gore.2021.100815
Source DB: PubMed Journal: Gynecol Oncol Rep ISSN: 2352-5789
Shows patients background characteristics, diagnoses and surgeries performed.
| Total | Arterial | Venous | ||
|---|---|---|---|---|
| Age | 59 (30–79) | 57.5 (35–72) | 59 (39–79) | |
| Body Mass Index (BMI) | 28.7 (16.4–49.2) | 31.45 (24.1–49.2) | 28.86 (16.4–45) | |
| Prior abdominal surgery (any) | 51% (27/52) | 54.5% (6/11) | 47.4% (18/38) | |
| Prior hysterectomy | 9.62% (5/52) | 9.1% (1/11) | 7.89% (3/38) | |
| Prior lymphadenectomy | 3.85% (2/52) | 9.1% (1/11) | 2.63% (1/38) | |
| Prior Pelvic Radiation | 9.62% (5/52) | 9.1% (1/11) | 10.5% (4/38) | |
| Ovarian Cancer | 28.8% (15/52) | 7.69% (1/13) | 28.9% (11/38) | |
| Uterine Cancer | 40.4% (21/52) | 53.8% (7/13) | 39.5% (15/38) | |
| Cervical Cancer | 19.2% (10/52) | 15.4% (2/13) | 21.1% (8/38) | |
| Vulvar/Vaginal Cancer | 3.8% (2/52) | 0.00% (0/13) | 5.13% (2/38) | |
| Recurrent Placental Site Trophoblastic Tumor | 1.92% (1/52) | 0.00% (0/13) | 2.63% (1/38) | |
| Benign/Preinvasive | 5.8% (3/52) | 23.1% (3/13) | 2.63% (1/38) | |
| Pelvic exenteration | 7 | 1 | 6 | |
| Simple Hysterectomy (+/- removal adnexa) | ||||
| Abdominal | 20 | 4 | 16 | |
| Laparoscopic | 3 | 1 | 2 | |
| Robotic | 4 | 2 | 2 | |
| Radical Hysterectomy (+/- removal adnexa) | ||||
| Abdominal | 9 | 2 | 7 | |
| Laparoscopic | 1 | 0 | 1 | |
| Robotic | 0 | 0 | 0 | |
| Pelvic lymphadenectomy | ||||
| Abdominal | 23 | 3 | 21 | |
| Laparoscopic | 3 | 0 | 3 | |
| Robotic | 4 | 2 | 2 | |
| Para-aortic lymphadenectomy | ||||
| Abdominal | 19 | 2 | 18 | |
| Laparoscopic | 1 | 0 | 1 | |
| Robotic | 1 | 0 | 1 | |
| Cytoreductive Surgery | 7 | 2 | 4 | |
| Oophorecotmy (without hysterectomy) | ||||
| Abdominal | 2 | 1 | 1 | |
| Laparoscopic | 0 | 0 | 0 | |
| Robotic | 0 | 0 | 0 | |
| Intestinal Surgery (not cytoreductive) | 1 | 1 | 0 | |
| Lysis of Adhesions | ||||
| Abdominal | 4 | 1 | 2 | |
| Laparoscopic | 2 | 1 | 1 | |
| Robotic | 0 | 0 | 0 | |
| Diagnostic laparoscopy | 4 | 3 | 1 | |
Shows location and mechanism of injury as well as means of repair. Intraoperative and postoperative complications are show. Percentage of postoperative complications are included for those postoperative course documentation was available.
| Location of Injury | Number | |
|---|---|---|
| Inferior vena cava | 32.7% (17/52) | |
| External iliac vein | 23.1% (12/52) | |
| External iliac artery | 15.4% (8/52) | |
| Complex/Multiple | 13.5%(7/52) | |
| Venous - unidentified, lumbar, sacral, retroperitoneal | 11.5% (6/52) | |
| Common iliac vein | 7.69% (4/52) | |
| Inferior mesenteric artery | 5.77% (3/52) | |
| Renal vein | 3.85% (2/52) | |
| Splenic Hilar vessel | 1.92% (1/52) | |
| Saphinous vein | 1.92% (1/52) | |
| Obturator Vein | 1.92% (1/52) | |
| Mesenteric vessels | 1.92% (1/52) | |
| Internal Iliac Vein | 1.92% (1/52) | |
| Internal iliac artery | 1.92% (1/52) | |
| Femoral Vein | 1.92% (1/52) | |
| Aorta | 1.92% (1/52) | |
| Lymph Node Dissection | 51.9% (27/52) | |
| Adhesiolysis/dissection of tumor | 15.4% (8/52) | |
| Retraction / Avulsion | 13.5% (7/52) | |
| Ureterolysis | 5.77% (3/52) | |
| Veres/Trocar Entry | 3.85% (2/52) | |
| Retroperitoneal Entry | 3.85% (2/52) | |
| Skin incision (groin) | 1.92% (1/52) | |
| Suture Repair | 80.8% (42/52) | |
| Hemostatic agent | 28.8% (15/52) | |
| Clip | 19.2% (10/52) | |
| Suture Ligation | 13.5% (7/52) | |
| Reanastamosis | 3.85% (2/52) | |
| Pressure alone | 3.85% (2/52) | |
| Splenectomy | 1.92% (1/52) | |
| Vascular graft | 1.92% (1/52) | |
| Estimated Blood Loss | 800 cc ( 100 - unquantifiable) | |
| Blood Transfusion | 2 (0–61) | |
| Change in Procedure | 15.4% (8/52) | |
| Intraoperative Vascular Consultation | 21.2% (11/52) | |
| Intraoperative Death | 1.9% (1/52) | |
| Postoperative Transfusion | 19.6% (9/46) | |
| Venous Thrombolism | 19/6% (9/46) | |
Demonstrates the procedure, mechanisms of injury and repair as well as complications specific to arterial injuries.
| Procedure | ||
|---|---|---|
| Laparoscopy | 53.9% (7/13) | |
| Laparotomy | 38.5% (5/13) | |
| Exenteration | 7.69% (1/13) | |
| Resection of mass or lysis of adhesions | 30.8% (4/13) | |
| Lymphadenectomy | 30.8% (4/13) | |
| Retraction avulsion | 15.38% (2/13) | |
| Ureterolysis | 7.69% (1/13) | |
| Entry into retroperitoneum | 7.69% (1/13) | |
| Direct trocar injury | 7.69% (1/13) | |
| Suture Repair | 76.9% (10/13) | |
| End-to-end anastamosis | 15.4% (2/13) | |
| Attempted interpositional graft | 7.69% (1/13) | |
| 975 mL (250- massive) | ||
| 2 (0–61) | ||
| Transfusion | 80% (8/10) | |
| Conversion to laparotomy | 85.7% (6/7) | |
| Intraoperative Vascular Consultation | 46.15% (6/13) | |
| Intraoperative Death | 7.69% (1/13) | |
| Transfusion | 15.38% (2/13) | |
| Venous Thromboembolism | 7.69% (1/13) | |
Demonstrates the procedure, mechanisms of injury and repair as well as complications specific to venous injuries.
| Laparoscopy | 15.8% (6/38) | |
| Laparotomy | 68.4% (26/38) | |
| Exenteration | 15.8% (6/38) | |
| Resection of tumor or lysis of adhesions | 10.5% (4/38) | |
| Lymphadenectomy | 63.2% (24/38) | |
| Retraction avulsion | 13.2% (5/38) | |
| Ureterolysis | 2.63% (1/38) | |
| Entry into retroperitoneum | 2.63% (1/38) | |
| Veres Needle Injury | 2.63% (1/38) | |
| Other / Unknown | 5.26% (2/38) | |
| Pressure alone | 5.26% (2/38) | |
| Hemostatic agent(s) | 34.2% (13/38) | |
| Clip | 23.7% (9/38) | |
| Suture | 81.6% (31/38) | |
| 750 (100–4000) | ||
| 1 (0–9) | ||
| Transfusion | 57.7% (15/26) | |
| Conversion to laparotomy | 33.3% (2/6) | |
| Intraoperative Vascular Consultation | 14.3% (4/28) | |
| Nerve Injury | 2.63% (1/38) | |
| Death | 0% (0/38) | |
| Transfusion | 21.9% (7/32) | |
| Venous Thromboembolism | 25.0% (8/32) | |